Read more about Wait and watch approach blamed for for 53% turnout for vaccine in Delhi on Business Standard. People adopting a "wait and watch" approach, lack of communication and glitches in CoWin app are the major reasons why only 53 per cent people got Covid shots on the first day in Delhi, experts said
COVID-19 Vaccination | 1,91,181 beneficiaries vaccinated as day 1 of world s biggest inoculation drive concludes | Highlights
COVID-19 Vaccination: The government has planned to vaccinate around 3 lakh healthcare workers at 2,934 session sites on the first day of the inoculation drive.
Updated: Sat, 16 Jan 2021 08:15 PM IST
File Image
New Delhi | Jagran News Desk: At least 1,91,181 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi. About 16,755 total vaccinators involved across India during the COVID vaccination drive. There was no post adverse event reported after the vaccination was administered to the people.
Delhi Vaccination: In all, 2.4 lakh healthcare workers in Delhi have registered for vaccination.
New Delhi:
The national capital has been one of the worst-hit by Covid-19 among Indian cities, with 6.31 lakh infected people till now and 10,732 deaths related to the pandemic. As the nation launches it massive fightback today with two vaccines, Delhi will be a key battlefront, with some of the biggest hospitals of the country, along with the several small local centres, forming the vanguard of the counteroffensive. The target is to inoculate 8,000 healthcare workers on day-1.
Vaccinations will begin to be administered in the city at 10.30 am at 81 different locations.
Updated Jan 16, 2021 | 17:23 IST
The Resident Doctors Association (RDA) of the Ram Manohar Lohia Hospital rejected Covaxin and requested the medical superintendent to vaccinate them with Oxford COVID-19 vaccine Covishield. Oxford COVID-19 vaccine Covishield
Key Highlights Covaxin manufactured by Bharat Biotech is being preferred in our hospital over Covishield manufactured by Serum Institute The residents are a bit apprehensive about the lack of complete trial in case of Covaxin We request you to vaccinate us with Covishield which has completed all stages of trial before its roll-out
New Delhi: Rejecting Covaxin due to ‘lack of complete trial’, resident doctors of Ram Manohar Lohia Hospital requested the medical superintendent to vaccinate them with Oxford COVID-19 vaccine Covishield.